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Abstract Two mouse genes, Mit1/Lb9 and Copg2, linked to
Peg1/Mest on mouse chromosome 6, were identified to be
imprinted maternally and paternally, respectively. Mit1/Lb9
encoding untranslated transcripts resides within the intron 20 of
Copg2. The gene is maternally imprinted in adult mouse brain,
partially imprinted in other tissues. Copg2 consists of 24 exons
within the s 40 kb genomic region, being expressed ubiquitously
in mouse tissues with a partial imprinting pattern in embryos,
neonates, and adult brain in contrast to maternally imprinted
human COPG2. In addition, we identified an antisense transcript
of Copg2, Copg2AS, which overlaps 3P-UTRs of Copg2 and
Peg1/Mest. The Copg2AS transcript is maternally imprinted in
embryos, neonates, and adult tissues.
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1. Introduction
Genomic imprinting is an epigenetic mechanism in mam-
mals that directs di¡erential silencing of a gene depending on
the parental allelic origin in the o¡spring’s soma [1,2]. More
than two dozens of human and mouse genes have been iden-
ti¢ed to be imprinted through various e¡orts including ge-
nome-wide systematic searches for monoallelically expressed
genes [3^9]. The clustering behavior of imprinted genes was
exploited in a strategic screening for the identi¢cation of new
imprinted genes. The increased wealth of genomic and EST
database enabled us to ambulate around four genomic regions
each of which contains only a single previously identi¢ed im-
printed gene. We have identi¢ed two mouse imprinted genes,
Mit1/Lb9 and Copg2, closely linked to Peg1/Mest. The expres-
sion pro¢les and imprinting patterns of the genes were deter-
mined.
2. Materials and methods
2.1. Determination of imprinting status
Human genes and ESTs closely linked to the known imprinted
genes were chosen from Human GeneMap’99 (http://www.ncbi.nlm.
nih.gov/genemap). Mouse homologues of the selected human genes
were identi¢ed from the GenBank database using BLAST programs.
Polymorphisms of the candidate genes were used to physically dis-
criminate one of parental alleles from the other in the F1 hybrids
crossed between two inbred mouse strains, C57BL/6J (a strain of
Mus musculus domesticus) and KJR/Msf (a strain of Mus musculus
molossinus). Restriction fragment length polymorphism (RFLP) anal-
yses of RT-PCR products were carried out to determine the allele-
speci¢c expression of the genes in the (KJR/MsfUC57BL/6J)F1 and
the (C57BL/6JUKJR/Msf)F1 hybrids. Total RNAs were isolated
using Tri reagent (Molecular Research Center). Reverse transcrip-
tion was performed with SuperScript II Reverse Transcriptase
(GibcoBRL) using random hexamer for Mit1/Lb9 or strand-speci¢c
primers for Copg2 and Copg2AS. The PCR primers 4^5 (5P-AA-
CAAAACTAGCTTTACTTGAGAG-3P) and 4^32 (5P-ATCTGTA-
ACTGTAACCCTGGGTCG-3P) were used for ampli¢cation of the
Mit1/Lb9 cDNA. The primer 4^32 ends at one nucleotide upstream
to the polymorphic site and contains a C residue rather than a native
G residue as the 3P-penultimate nucleotide. Therefore, the PCR prod-
uct of the KJR/Msf allele would be digested by TaqI restriction en-
zyme while that of the C57BL/6J allele would not (see Fig. 4A). The
PCR products were digested with TaqI restriction enzyme and ana-
lyzed on a 5% polyacrylamide gel. PCR ampli¢cations were carried
out for 33 cycles in 50 Wl of 10 mM Tris^HCl (pH 8.3), 40 mM KCl,
1.5 mM MgCl2, 1 mM DTT, 0.5 Wg/ml acetylated BSA, and 200 WM
of each dNTP with 50 pmol of each primer and 2.5 units of Taq DNA
polymerase at 94‡C for 30 s, at 55‡C for 30 s, and at 72‡C for 30 s.
The PCR primers G2-F1 (5P-GCTGCTGCCTGGGAAGAGGT-3P)
and G2-PF (5P-GAAGAAACTCTAAAGCTCATGCTC-3P) located
in exon 20 and exon 24, respectively, were used for ampli¢cation of
the Copg2 cDNA. To amplify the Copg2AS cDNA, the PCR primers
G2-PR (5P-GGCCCTGCGCCAGCAGATCAAACA-3P) and Peg1-
3UF (5P-CCTAAGAGCAAATGGTGCTG-3P) located in exon 24
of Copg2 and exon 12 of Peg1/Mest, respectively, were used. The
PCR ampli¢cations were performed under the same conditions as
above except that the annealing temperature was 62‡C. Genomic
DNA was ampli¢ed using G2-PR and G2-PF primers. The PCR
products of Copg2 and Copg2AS were digested with HhaI and BsmAI
restriction enzymes, respectively and analyzed on a 20% polyacryl-
amide gel.
2.2. Characterization of cDNA and genomic DNA clones
Six cDNA clones of Mit1/Lb9 and three cDNA clones of Copg2
were isolated from mouse brain cDNA library and testis cDNA li-
brary, respectively. Six genomic clones for Mit1/Lb9 and Copg2 were
isolated from mouse 129 genomic DNA library. Library screening was
carried out according to the standard protocol. The nucleotide se-
quences were determined using a TaqTrak Sequencing System (Prom-
ega) and a Bigdye Terminator cycle sequencing kit (Perkin-Elmer).
2.3. Southern blot and Northern blot analyses
Fifteen micrograms of mouse genomic DNA were digested with
StuI, BglII, PvuII, HindIII, EcoRI, XbaI, or DraI, electrophoresed
on a 0.8% agarose gel, and transferred to a Hybond-N membrane
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(Amersham) in the Southern hybridization experiment. Thirty micro-
grams of total RNAs were electrophoresed on a 1% agarose gel and
transferred to a Hybond-N membrane for the Northern hybridiza-
tion. The [K-32P]dCTP random primed Mit1/Lb9 and Copg2 cDNAs
were used as the probes. Hybridization was carried out at 65‡C using
the QuickHyb solution (Stratagene).
3. Results
3.1. Isolation and characterization of Mit1/Lb9 and Copg2
We investigated parent of origin-speci¢c expression patterns
of 12 mouse genes of which human homologues are closely
linked to Peg1/Mest [10], PEG3 [11], PEG5/NNAT [12], and
MEG1/GRB10 [13]. It has not been investigated whether the
genomic regions of those imprinted genes harbor additional
imprinted genes yet. The allelic expression patterns of the 12
candidates were determined in the F1 hybrids of C57BL/6J (a
strain of Mus musculus domesticus) and KJR/Msf (a strain of
Mus musculus molossinus). Mouse homologues of UBE2H,
IRF5, KIAA0265, Cda15a02, and CALU linked to Peg1/
Mest, WI-8030, EMAP2, AAD23609.1, and CGI-146 linked
to PEG3, RBL1 linked to PEG5/NNAT, and TTC4 linked to
MEG1/GRB10 were ascertained to be expressed biallelically in
adult mouse brain, heart, lung, and kidney (data not shown).
However, a gene closely linked to Peg1/Mest, a maternally
imprinted gene on mouse chromosome 6 [3], was identi¢ed
to be imprinted. It was found that the mouse cDNA sequence
(GenBank accession no. AA611551), a homologue of a hu-
man clone 23582 (GenBank accession no. AF038190), was
maternally imprinted in mouse brain (see below). The gene
was designated as Mit1 (Mest-linked imprinted transcript 1;
GenBank accession no. AF217545). It shares 67.3% nucleo-
tide sequence identity with human clone 23582. Subsequently,
cDNA and genomic DNA clones of Mit1 were isolated and
characterized. Sequencing analyses showed that Mit1 is lo-
cated within the intron 20 of an adjacent gene, Copg2 (Fig.
1), a homologue of coatomer protein complex subunit Q
(Q-COP) [21] (Fig. 2A). Copg2 shares 80.8% amino acid se-
quence identity with mouse Copg1 (GenBank accession no.
AF187079) (Fig. 1) and 97.6% amino acid sequence identity
with human COPG2 [9]. A CpG island was found in the 5P-
region of Copg2 (Fig. 2A). The 3P-UTR of Copg2 overlapped
at its terminal 52 nucleotides with the 3P-UTR of Peg1/Mest
(Fig. 2A). The overlapping is conserved in mouse, human [9],
and rat (GenBank accession nos. AI408151 and AA851833).
The exon^intron boundaries of mouse Copg2 and human
COPG2 are conserved. Database analyses of the cDNA and
genomic DNA sequences of Mit1 revealed that the previously
identi¢ed Lb9 cDNA (GenBank accession no. U20263) was
located at the upstream of Mit1 (Fig. 2A). RT-PCR experi-
ments using the PCR primers, one of which annealed to the
Fig. 1. Comparison of deduced amino acid sequences between mouse Copg1 and mouse Copg2. Identical amino acids are shaded.
Fig. 2. Genomic organization of Mit1/Lb9 and Copg2. A: Genomic
structure of Mit1/Lb9 and Copg2. The protein coding regions are
indicated by solid boxes. Open boxes represent 3P-UTRs of Copg2
and Peg1/Mest. Mit1 cDNA and Lb9 cDNA are indicated by
hatched boxes. Introns of which the sizes were determined are repre-
sented by horizontal lines. Transcriptional orientations of Mit1/Lb9,
Copg2, and Peg1/Mest are indicated by arrows. Translation start co-
don (ATG), stop codon (TAA), and CpG island of Copg2 are indi-
cated. B: Southern blot analysis of Mit1/Lb9. The size markers are
indicated in kb.
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Lb9 cDNA and the other to the Mit1 cDNA, showed both
sequences were within the same gene transcript (data not
shown).
Mit1/Lb9 is a single copy gene as shown by Southern blot
analysis (Fig. 2B). The transcription products of Mit1/Lb9
seem to be highly heterogeneous since multiple transcripts
were detected in Northern blot analysis (Fig. 3A). In addition,
we could ¢nd six di¡erent forms of the Lb9 cDNA (GenBank
accession nos. U20262^U20267) from the GenBank database.
It is likely that the observed multiple Mit1/Lb9 transcripts are
generated by alternative splicing and/or di¡erential usage of
promoters and polyadenylation sites. It is of interest that no
considerable open reading frame could be predicted from the
sequences of Mit1/Lb9 cDNAs. It seems that Mit1/Lb9 func-
tions at the RNA level as H19 [14], Igf2rAS [15], IPW [16], or
LIT1 [17] does.
3.2. Expression of Mit1/Lb9 and Copg2
The expression patterns of Mit1/Lb9 and Copg2 were de-
termined by Northern blot analyses with total RNAs isolated
from various tissues (Fig. 3). The transcription level of Mit1/
Lb9 varied among di¡erent tissues (Fig. 3A). The expression
of Mit1/Lb9 was highest in brain. The major transcript, about
7 kb in length, was also expressed in heart, lung, and muscle,
while the expression in other tissues was negligible. On the
other hand, Copg2 was ubiquitously expressed in most mouse
tissues with the highest expression in testis where the Mit1/
Lb9 was hardly expressed (Fig. 3B). The major transcript of
Copg2 was about 3 kb in length.
3.3. Imprinting status of Mit1/Lb9 and Copg2
The imprinting status of Mit1/Lb9 was determined using a
single base polymorphism between mouse strains, C57BL/6J
and KJR/Msf. Since the polymorphism did not provide any
available RFLP site, mismatch PCR-mediated site-directed
Fig. 3. Expression analyses of Mit1/Lb9 and Copg2. Total RNAs
from di¡erent tissues of mouse were blotted and hybridized with
Mit1/Lb9 (A) or Copg2 (B) cDNA as a probe. Reprobing of the
same blot with the L-actin probe was used for the control.
Fig. 4. Determination of imprinting status of Mit1/Lb9. A: Ex-
pected restriction DNA fragments using mismatch PCR-mediated
site-directed mutagenesis. The polymorphic site between C57BL/6J
and KJR/Msf is indicated in boldface. The mismatched base in the
primer 4^32 is shown in lowercase. Polymorphic TaqI site created in
the KJR/Msf allele is underlined. B: Imprinting status of Mit1/Lb9
in adult tissues. RNAs derived from the (C57BL/6JUKJR/Msf)F1
hybrid (CUM) and the (KJR/MsfUC57BL/6J)F1 hybrid (MUC)
were used for RT-PCR ampli¢cation. PCR products were digested
with TaqI and separated on a 5% polyacrylamide gel. C: Imprinting
status of Mit1/Lb9 in mouse embryos and neonates. C57BL,
C57BL/6J allele; Mol, KJR/Msf allele; E17.5H, head of E17.5;
E17.5B, body of E17.5; NeoH, head of neonate; NeoB, body of
neonate.
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mutagenesis [18] was used for the discrimination of the ex-
pressed alleles (see Section 2 and Fig. 4A). The single base
polymorphism and the mismatch PCR primer introduced a
TaqI restriction enzyme site in the RT-PCR product of the
KJR/Msf allele, but not in that of the C57BL/6J allele. The
KJR/Msf allele was exclusively expressed in brain of the
(C57BL/6JUKJR/Msf)F1 hybrid while the C57BL/6J allele
was expressed in the reciprocal (KJR/MsfUC57BL/6J)F1 hy-
brid (Fig. 4B). However, relaxed imprinting patterns were
observed in heart, lung and muscle. The expression level of
the C57BL/6J allele was higher than that of the KJR/Msf
allele in these tissues of the (KJR/MsfUC57BL/6J)F1 hybrid.
In the reciprocal (C57BL/6JUKJR/Msf)F1 hybrid, both al-
leles were expressed at comparable levels in the same tissues
(Fig. 4B). The imprinting status of Mit1/Lb9 in mouse em-
bryos and neonates was investigated to determine the devel-
opmental stage at which the imprinting of Mit1/Lb9 is estab-
lished (Fig. 4C). Mit1/Lb9 was apparently imprinted in E13.5
embryos, E17.5 embryos, and in neonates. However, E11.5
embryos exhibited a relaxed imprinting pattern. The result
suggests that the imprinted expression pattern of Mit1/Lb9
is established at around E13.5.
The four-nucleotide length polymorphism between C57BL/
6J and KJR/Msf was used to determine the imprinting status
of Copg2 (Fig. 5A). We initially obtained inconsistent imprint-
ing patterns with di¡erent primer sets. Such an inconsistency
raised the possibility for the existence of the antisense tran-
script of Copg2. We prepared strand-speci¢c RT products as
PCR templates to distinguish Copg2 from its antisense tran-
script, Copg2AS (Fig. 5A). In contrast to human COPG2
reported to be maternally imprinted in several human fetal
tissues [9], mouse Copg2 is paternally imprinted. Majority of
the Copg2 transcripts was expressed from the maternal allele
in brain (Fig. 5B). Similar imprinting patterns of Copg2 were
Fig. 5. Determination of imprinting status of Copg2 and Copg2AS. A: Nucleotide sequences of the region containing a length polymorphism
between C57BL/6J and KJR/Msf. Annealing sites of primers G2-F1, G2-PF, G2-PR, and Peg1-3UF are indicated. Strand-speci¢c reverse tran-
scription was performed using primer G2-PF for Copg2 or G2-PR for Copg2AS. The RT-PCR product of Copg2 transcript was ampli¢ed with
G2-F1 and G2-PF and digested with HhaI. The reverse-transcribed product of Copg2AS transcript was ampli¢ed with Peg1-3UF and G2-PR
and digested with BsmAI. Digested DNA fragments were separated on a 20% polyacrylamide gel. Expected restriction DNA fragments are rep-
resented. Transcripts of Copg2, Copg2AS, and Peg1/Mest are indicated by arrows. B: Imprinting status of Copg2 in adult tissues and in mouse
embryos and neonates. C: Imprinting status of Copg2AS in adult tissues and in mouse embryos and neonates. Imprinting status was deter-
mined in the (C57BL/6JUKJR/Msf)F1 hybrid (CUM) and the (KJR/MsfUC57BL/6J)F1 hybrid (MUC). C57BL, C57BL/6J allele; Mol, KJR/
Msf allele; C, C57BL/6J; M, KJR/Msf; G, genomic DNA of the (C57BL/6JUKJR/Msf)F1 hybrid; E17.5H, head of E17.5; E17.5B, body of
E17.5; NeoH, head of neonate; NeoB, body of neonate.
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also observed in mouse embryos and neonates (Fig. 5B). Cop-
g2AS was maternally imprinted in tested adult tissues, em-
bryos, and neonates (Fig. 5C). Copg2AS spans 3P-UTR of
Peg1/Mest and 3P-UTR of Copg2. It is unclear that Copg2AS
is a part of the heterogeneous Mit1/Lb9 transcripts or an
uncharacterized Peg1/Mest transcript.
4. Discussion
We have demonstrated that Copg2 is parternally imprinted
in mouse brain and the whole embryo in a relaxed manner.
The relaxed imprinting pattern of Copg2 shown in this study
can be ascribed to the partial imprinting in whole tissues or
the tissue-speci¢c imprinting in the whole embryo since we
used total RNA of the whole embryos to determine the im-
printing status of Copg2. The imprinting strengths of Mit1/
Lb9 in heart, lung, and muscle are di¡erent between (C57BL/
6JUKJR/Msf)F1 hybrid and (KJR/MsfUC57BL/6J)F1 hy-
brid. The inconsistency can be explained by enhanced lability
of imprinted expression pattern under some epigenetic envi-
ronments including strain-speci¢c genetic background as dem-
onstrated in the imprinting pattern of mouse Kvlqt1 [19].
It is striking that mouse Copg2 is paternally imprinted in
contrast to human orthologue COPG2 which was reported to
be maternally imprinted in several human fetal tissues [9].
Alternatively, putative antisense transcripts of COPG2 might
have obscured the imprinting status of human COPG2 since
Blagitko et al. used random hexamer primers for reverse
transcription to determine the allelic expression of COPG2
[9].
The allele-speci¢c expression is correlated with dynamic
change in the allele-speci¢c methylation at CpG island(s)
[20]. The CpG island of Copg2 is a good candidate target
for the allele-speci¢c di¡erential methylation. The methylation
status of the CpG island is currently being investigated.
Maternal uniparental disomy (UPD) of proximal region of
mouse chromosome 6 is associated with embryonic lethality
[20]. The overexpression of Copg2 or the absence of Mit1/Lb9
or Copg2AS transcript in the maternal UPD embryo might
have caused the embryonic lethality. The sub-proximal end of
mouse chromosome 6 shows a conserved synteny with human
chromosomal region 7q31^35 [3,10]. The maternal UPD of
human chromosome 7 has been reported in approximately
10% of Silver-Russell syndrome (SRS) cases [21,22], suggest-
ing that imprinted gene(s) on human chromosome 7 is respon-
sible for SRS phenotype in the UPD patients [23]. The im-
printed COPG2 and/or its antisense transcripts including
human orthologue of mouse Mit1/Lb9 can be candidate genes
for the SRS.
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